skip to main content
Idioma:
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Thalidomide and dexamethasone combination for refractory multiple myeloma
Thalidomide and dexamethasone combination for refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Thalidomide and dexamethasone combination for refractory multiple myeloma

Dimopoulos, M. A. ; Zervas, K. ; Kouvatseas, G. ; Galani, E. ; Grigoraki, V. ; Kiamouris, Ch ; Vervessou, E. ; Samantas, E. ; Papadimitriou, Ch ; Ecomomou, O. ; Gika, D. ; Panayiotidis, P. ; Christakis, I. ; Anagnostopoulos, N.

Annals of oncology, 2001-07, Vol.12 (7), p.991-995 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
2
Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia
Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia

Dimopoulos, M. A. ; Hamilos, G. ; Zervas, K. ; Symeonidis, A. ; Kouvatseas, G. ; Roussou, P. ; Gika, D. ; Karmiris, T. ; Bourantas, K. ; Zomas, A. ; Mitsouli, C. ; Xilouri, I. ; Vervessou, E. ; Matsis, K. ; Anagnostopoulos, N. ; Economopoulos, T.

Annals of oncology, 2003-08, Vol.14 (8), p.1299-1305 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy
Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

Kastritis, Efstathios ; Kyrtsonis, Marie-Christine ; Morel, Pierre ; Gavriatopoulou, Maria ; Hatjiharissi, Evdoxia ; Symeonidis, Argirios S ; Vassou, Amalia ; Repousis, Panagiotis ; Delimpasi, Sossana ; Sioni, Anastasia ; Michalis, Evrydiki ; Michael, Michail ; Vervessou, Elina ; Voulgarelis, Michael ; Tsatalas, Costantinos ; Terpos, Evangelos ; Dimopoulos, Meletios A

Haematologica (Roma), 2015-11, Vol.100 (11), p.e446-e449 [Periódico revisado por pares]

Italy: Ferrata Storti Foundation

Texto completo disponível

Citações Citado por
4
224 Factors affecting leukemic transformation in patients with del-5q treated with lenalidomide
224 Factors affecting leukemic transformation in patients with del-5q treated with lenalidomide
Material Type:
Artigo 		Adicionar ao Meu Espaço

224 Factors affecting leukemic transformation in patients with del-5q treated with lenalidomide

Symeonidis, A ; Galanopoulos, A ; Hatzimichail, E ; Loukidis, C ; Kouraklis, A ; Kartasis, Z ; Kokkini, G ; Vyniou, N ; Pappa, V ; Vagia, M ; Protopapa, M ; Chaliori, I ; Vervessou, E ; Laoutaris, N ; Anagnostopoulos, N ; Panagiotidis, P

Leukemia research, 2011, Vol.35, p.S88-S88 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
P130 Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience
P130 Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

P130 Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience

Pappa, V ; Papageorgiou, S ; Tsirigotis, P ; Dervenoulas, J ; Girkas, K ; Papageorgiou, E ; Poulakidas, H ; Papadaki, E ; Galanopoulos, A ; Vervessou, E ; Panayotidis, P ; Zomas, A ; Symeonidis, A ; Economopoulos, T

Leukemia research, 2009-05, Vol.33, p.S134-S135 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
Material Type:
Artigo 		Adicionar ao Meu Espaço

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

Jones, Amy V. ; Kreil, Sebastian ; Zoi, Katerina ; Waghorn, Katherine ; Curtis, Claire ; Zhang, Lingyan ; Score, Joannah ; Seear, Rachel ; Chase, Andrew J. ; Grand, Francis H. ; White, Helen ; Zoi, Christine ; Loukopoulos, Dimitris ; Terpos, Evangelos ; Vervessou, Elisavet-Christine ; Schultheis, Beate ; Emig, Michael ; Ernst, Thomas ; Lengfelder, Eva ; Hehlmann, Rüdiger ; Hochhaus, Andreas ; Oscier, David ; Silver, Richard T. ; Reiter, Andreas ; Cross, Nicholas C.P.

Blood, 2005-09, Vol.106 (6), p.2162-2168 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
7
13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factor
13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factor
Material Type:
Artigo 		Adicionar ao Meu Espaço

13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factor

Solomou, E E ; Sfikakis, P P ; Kotsi, P ; Papaioannou, M ; Karali, V ; Vervessou, E ; Hoffbrand, A V ; Panayiotidis, P

Leukemia & lymphoma, 2003-09, Vol.44 (9), p.1579-1585 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
8
13q Deletion in Chronic Lymphocytic Leukemia: Characterization of E4.5, a Novel Chromosome Condensation Regulator-like Guanine Nucleotide Exchange Factor
13q Deletion in Chronic Lymphocytic Leukemia: Characterization of E4.5, a Novel Chromosome Condensation Regulator-like Guanine Nucleotide Exchange Factor
Material Type:
Artigo 		Adicionar ao Meu Espaço

13q Deletion in Chronic Lymphocytic Leukemia: Characterization of E4.5, a Novel Chromosome Condensation Regulator-like Guanine Nucleotide Exchange Factor

Solomou, E. E. ; Sfikakis, P. P. ; Kotsi, P. ; Papaioannou, M. ; Karali, V. ; Vervessou, E. ; Hoffbrand, A. V. ; Panayiotidis, P.

Leukemia & lymphoma, 2003, Vol.44 (9), p.1579-1585 [Periódico revisado por pares]

Informa UK Ltd

Texto completo disponível

Citações Citado por
9
Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia
Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia

Dimopoulos, Meletios A. ; Zervas, Constantinos ; Zomas, Athanasios ; Hamilos, George ; Gika, Dimitra ; Efstathiou, Eleni ; Panayiotidis, Panayiotis ; Vervessou, Elina ; Anagnostopoulos, Nikolaos ; Christakis, John

Clinical lymphoma, 2002-12, Vol.3 (3), p.163-166

United States

Sem texto completo

Citações Citado por
10
Bortezomib reduces serum dickkopf‐1 and receptor activator of nuclear factor‐κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
Bortezomib reduces serum dickkopf‐1 and receptor activator of nuclear factor‐κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib reduces serum dickkopf‐1 and receptor activator of nuclear factor‐κB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma

Terpos, Evangelos ; Heath, Deborah J. ; Rahemtulla, Amin ; Zervas, Kostas ; Chantry, Andrew ; Anagnostopoulos, Athanasios ; Pouli, Anastasia ; Katodritou, Eirini ; Verrou, Evgenia ; Vervessou, Elisavet‐Christine ; Dimopoulos, Meletios‐Athanassios ; Croucher, Peter I.

British journal of haematology, 2006-12, Vol.135 (5), p.688-692 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (9)
  2. Revistas revisadas por pares (9)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.